Latest Threlkeld News
The latest news and updates about the Threlkeld One-Name Study,
plus occasional at-a-glance snippets about family history happenings

In conjunction with its annual MyHeritage Live event in Amsterdam, the growing genetic genealogy company based in Israel announced today that is has acquired River Road Bio, the entity that owns and operates both Promethease and SNPedia. This is the tenth business acquisition by MyHeritage.

SNPedia is a community-curated database and Wiki knowledgebase containing information for over 110,400 variants, connecting them with over 30,000 scientific publications. Promethease uses these data to compare consumer-uploaded DNA test results in order to find possibly relevant correlations to the users' unique genomes.

MyHeritage says that it intends to keep Promethease independent from its own branded DNA health/clinical products. Promethease previously cost $12 to upload DNA test results, but MyHeritage announced that it will be free through at least December 31. Of note, however, is that in November 2019 DNA test results uploaded and stored at Promethease will automatically be uploaded to the MyHeritage database. European Union citizens and residents will be afforded an opt-out of the automatic data transfer to MyHeritage; others not wishing their results automatically uploaded will need to manually delete them before November.

SNPedia is a free resource for non-commercial use and operates under a Creative Commons license. MyHeritage will now have sole ability to make use of SNPedia commercially.

Said Dr. Yaniv Erlich, Chief Science Officer for MyHeritage, "The acquisition of SNPedia and Promethease expands MyHeritage's intellectual property in medical genetics. Going forward, SNPedia will empower us to broaden the scope of health reports provided by the MyHeritage DNA Health+Ancestry test and propel it to become a global market leader in consumer DNA testing. We are happy to keep SNPedia as a free resource for the academic community and for consumers."

This follows the 14 August announcement by CEO Margo Georgiadis that the largest of the direct-to-consumer DNA testing companies is expanding into individualized medicine and "is building out a full health team, with open roles in marketing, engineering, communications, and senior management."

See also: Business Wire, 7 September 2019, 4:20 a.m. EDT

Items of interest at Please use the search bar below the ads to locate specific products:

As an Amazon Associate I earn from qualifying purchases. If you choose to purchase via one of these links, I earn a small referral fee to help maintain our operations, and you never pay a penny more than you would if you didn't link through us. Thanks for looking!